“…Many human cancers, including brain tumors, primarily metabolize glucose (Glc) to lactate for ATP production, a phenomenon known as the Warburg effect [ 2 , 3 , 4 ]. Recently it has become apparent that malignant brain tumors also catabolize a wide range of circulating nutrients, including fatty acids, ketone bodies, amino acids, and acetate [ 2 , 5 , 6 , 7 ]. Glut3 (SLC2A3) is the major transporter of Glc in GBM, with its elevated levels indicative of poor patient outcomes [ 8 , 9 , 10 , 11 , 12 ].…”